Regional News

IASO Bio and Innovent Present New Data of FUCASO® (Equecabtagene Autoleucel) for Multiple Myeloma Patients in Oral Presentation at ASH 2023

SHANGHAI and NANJING, China and SAN JOSE, Calif., Dec. 11, 2023 /PRNewswire/ -- IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, and Innovent Biologics, Inc. ("Innovent", H...

2023-12-12 03:30 1224

Star Charge Expands its Manufacturing to USA in Central Ohio to Meet Increasing Needs

FREMONT, Calif., Dec. 11, 2023 /PRNewswire/ -- Star Charge, a global leader in Electric Vehicle Charging Infrastructure with a proven track record of delivering up to 2 million EV chargers in more than 60 countries, is excited to announce the expansion of its manufacturing facility to theUSA with...

2023-12-12 02:30 1312

STRADVISION CTO, Jack Sim, Unveils Innovative Deep Learning Development Methodology at Tech.AD USA 2023

* Efficient Deep Learning: CTO Jack Sim unveils a streamlined development process through teacher-student learning and sprints * Swift Product Releases: Reduces development time by 50%, enabling rapid creation of ImmersiView™ and monthly software releases * Adaptable 3D Perception: The metho...

2023-12-12 00:00 1402

Kyrie Irving Announces Investment In KICKS CREW, The World's Fastest-Growing Sneaker Community And Marketplace

 8x NBA All-Star Joins Startup as Chief Community Officer, Kicking Off 11 Days Of Giving Philanthropic Initiative with ANTA Shock Wave 5 Giveaway NEW YORK, Dec. 11, 2023 /PRNewswire/ -- KICKS CREW, the leading global digital marketplace for authentic sneakers and apparel, announces an investor p...

2023-12-12 00:00 1316

ITRI's VLSI TSA Symposium to Kick Off in April 2024

HSINCHU, Dec. 11, 2023 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI) will host the 2024 International VLSI Symposium on Technology, Systems and Applications (VLSI TSA ) from April 22 to 25, 2024 at the Ambassador Hotel Hsinchu, Taiwan. E...

2023-12-11 23:00 1321

SEG Solar Awarded Silver Medal in EcoVadis CSR Rating

HOUSTON, Dec. 11, 2023 /PRNewswire/ -- SEG Solar (SEG) recently received a silver rating from EcoVadis for its superior performance, securing a top 18% position among assessed companies and obtaining a notable score of 80/100 in the labor and human rights category. This award recognizes SEG as an...

2023-12-11 23:00 1140

Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project

* After a successful stage 1, Lunit INSIGHT MMG moves to prospective validation inAustralia's BreastScreen NSW Machine Reading Solution Project SEOUL, South Korea, Dec. 11, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therape...

2023-12-11 22:30 1433

Hollysys to be Acquired by Ascendent Capital Partners for US$26.50 in Cash Per Share

* Hollysys Board has unanimously approved Ascendent's all cash offer at 42% premium to the unaffected price as of23 August 2023 * Agreement marks culmination of formal sale process conducted by Special Committee of independent directors BEIJING, Dec. 11, 2023 /PRNewswire/ -- Hollysys Automati...

2023-12-11 22:10 2534

CLASS101 Joins Forces with MarqVision in a Pioneering Partnership to Safeguard the Intellectual Property of Its Creators

SEOUL, South Korea, Dec. 11, 2023 /PRNewswire/ -- CLASS101 (CEO Daisun Kong), South Korea's top online learning platform, today announced that it has entered into an industry-pioneering partnership with MarqVision. In joining forces with MarqVision, the world's first AI-powered Growth Protection ...

2023-12-11 22:00 1343

HEYTEA Brews Success on Broadway: Inaugural US Store Achieves Record Sales and Sparks "HEYTEA Buzz" in NYC

The Broadway debut marks HEYTEA's successful entry into the U.S. market, showcasing commitment to delivering authentic tea products and joy-inspiring brand experiences NEW YORK, Dec. 11, 2023 /PRNewswire/ -- On December 8, HEYTEA's inaugural store inthe United States officially opened on Broadwa...

2023-12-11 22:00 1345

Webull Welcomes Arianne Adams as Chief Strategy Officer

Adams brings decades of financial experience and industry knowledge to leading brokerage NEW YORK, Dec. 11, 2023 /PRNewswire/ -- Webull , a leading commission-free trading platform with over 40 million downloads globally, today announced the appointment ofArianne Adams as...

2023-12-11 22:00 1162

Ideal Christmas Gift Ideas for Your Loved Ones in 2023

LOS ANGELES, Dec. 11, 2023 /PRNewswire/ -- As the year-end holiday season approaches, Christmas is just around the corner! It's the perfect moment to kick off your shopping for those essential gifts. The yeedi holiday gift guide showcases a variety of robot vacuums tailored to meet the cleaning n...

2023-12-11 22:00 1116

Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"),...

2023-12-11 21:00 2373

WiMi Developed Holographic Complex Amplitude Computation and Update Technology

BEIJING, Dec. 11, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it successfully developed a new technology----"Holographic Complex Amplitude Computation and Updat...

2023-12-11 21:00 1349

"K-Beauty Tech Shines in the U.S." APR Corp. to Showcase Beauty Device Technology at CES 2024

* The world's largest IT-Home Appliance Trade Show, "CES 2024" in Las Vegas, Nevada.  * APR Corps will participate under the category of 'lifestyle'  * First participation ever since its establishment  * Plans to reveal new products for U.S. launch in addition to currently exporting produc...

2023-12-11 21:00 1550

Yingli Pharma presents a pivotal Phase 2 study data evaluating linperlisib in relapsed or refractory peripheral T-cell lymphoma in an oral session at the American Society of Hematology 2023 Annual Meeting

Linperlisib achieved Overall Response Rate of 48% with 30% being Complete Response and manageable safety profile in the r/r PTCL phase 2 study SHANGHAI and SAN FRANCISCO, Dec. 11, 2023 /PRNewswire/ -- Shanghai Yingli Pharmaceutical Co., Ltd. ("Yingli Pharma"), a biopharmaceutical company focused ...

2023-12-11 21:00 1297

Guide Sensmart was present at Big 5 Global 2023, advocating for the digitalization of inspections for building HVAC systems

WUHAN, China, Dec. 11, 2023 /PRNewswire/ -- As the largest HVACR exhibition in theMiddle East, the Big 5 Global 2023 was grandly held at the Dubai World Trade Centre in theUnited Arab Emirates from December 4th to December 7th. The four-day event attracted outstanding HVAC equipment manufacturers...

2023-12-11 21:00 1195

DST Raises US$80 Million in Latest Round of Financing

China's Leading NEV Fleet Management Company Secures One of the Largest US Dollar Private Investments in 2023  Highlights: * DST aims to expand the scale of its NEV fleet in China as well as to deepen its R&D efforts, increase offline service network, and offer comprehensive and tailor-made s...

2023-12-11 21:00 1241

INNOVATION TO INSPIRE, A WONDEROUS FUTURE | Tianma 2023 Global Innovation Conference, Seven Innovative Achievements Unveiled

XIAMEN, China, Dec. 11, 2023 /PRNewswire/ -- On November 27th, Tianma Innovation Conference (TIC) 2023 was held inXiamen with the theme of INNOVATION TO INSPIRE, A WONDEROUS FUTURE. Seven Innovative Achievements Seven I...

2023-12-11 20:21 1287

HanAll Biopharma's Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors

WOBURN, Mass., Dec. 11, 2023 /PRNewswire/ -- HanAll Biopharma's partner NurrOn Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson's disease (PD) and other Nurr1-related human disorders, is pleased to...

2023-12-11 20:00 1087